A decline in platelet activation and inflammatory cell infiltration is associated with the phenotypic redifferentiation of neointimal smooth muscle cells after bare-metal stent implantation in acute coronary syndrome

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 7, 2010, Pages 675-687

  Nakagawa, Masashi ^a   Naruko, Takahiko ^b   Ikura, Yoshihiro ^a   Komatsu, Ryushi ^b   Iwasa, Yoko ^a   Kitabayashi, Chizuko ^a   Inoue, Takeshi ^b   Itoh, Akira ^b   Yoshiyama, Minoru ^a   Ueda, Makiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Neointima; P selectin; Pathology; Platelets; Stents

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR; HEPARIN; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SMOOTH MUSCLE ACTIN; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; AUTOPSY; BARE METAL STENT; CELL DIFFERENTIATION; CELL REGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTIMA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MACROPHAGE; MALE; METAL IMPLANTATION; MORPHOLOGICAL TRAIT; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; RIGHT CORONARY ARTERY; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; UNSTABLE ANGINA PECTORIS;

EID: 77955830246     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.3426     Document Type: Article

References (37)

1. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, Kozuma K, Van Langenhove G, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW: Sustained suppression of neointimal proliferation by sirolimuselutingstents: one-year angiographic and intravascular ultrasound follow-up. Circulation, 2001; 104: 2007-2011
2. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW: Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet, 2004; 364: 1519-1521
3. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW: Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet, 2007; 369: 667-678
4. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R: Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation, 2008; 118: 1138-1145
5. Ueda M, Becker AE, Fujimoto T, Tsukada T: The early phenomena of restenosis following percutaneous transluminal coronary angioplasty. Eur Heart J, 1991; 12: 937-945
6. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, Virmani R: Pathology of acute and chronic coronary stenting in humans. Circulation, 1999; 99: 44-52
7. Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE: Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation, 1998; 98: 224-233
8. Lefkovits J, Plow EF, Topol EJ: Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med, 1995; 332: 1553-1559
9. McEver RP, Martin MN: A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem, 1984; 259: 9799-9804
10. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF: A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol, 1985; 101: 880-886
11. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B: A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest, 1986; 78: 130-137
12. Johnston GI, Cook RG, McEver RP: Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell, 1989; 56: 1033-1044
13. Becker RC: The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group. Coron Artery Dis, 1994; 5: 339-345
14. Shoji T, Koyama H, Fukumoto S, Maeno T, Yokoyama H, Shinohara K, Emoto M, Shoji T, Inaba M, Nishizawa Y: Platelet-monocyte aggregates are independently associated with occurrence of carotid plaques in type 2 diabetic patients. J Atheroscler Thromb, 2005; 12: 344-352
15. Hayashi S, Watanabe N, Nakazawa K, Suzuki J, Tsushima K, Tamatani T, Sakamoto S, Isobe M: Roles of P-selectin in inflammation, neointimal formation, and vascular remodeling in balloon-injured rat carotid arteries. Circulation, 2000; 102: 1710-1717
16. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T: Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation, 1991; 83: 1327-1332
17. Kocher O, Skalli O, Bloom WS, Gabbiani G: Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab Invest, 1984; 50: 645-652
18. Ueda M, Becker AE, Naruko T, Kojima A: Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans. Coron Artery Dis, 1995; 6: 71-81
19. Takagi M, Ueda M, Becker AE, Takeuchi K, Takeda T: The Watanabe heritable hyperlipidemic rabbit is a suitable experimental model to study differences in tissue response between intimal and medical injury after balloon angioplasty. Arterioscler Thromb Vasc Biol, 1997; 17: 3611-3619
20. Blank RS, Owens GK: Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. J Cell Physiol, 1990; 142: 635-642
21. Holycross BJ, Blank RS, Thompson MM, Peach MJ, Owens GK: Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res, 1992; 71: 1525-1532
22. Ueda M, Becker AE, Kasayuki N, Kojima A, Morita Y, Tanaka S: In situ detection of platelet-derived growth factor-A and-B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am J Pathol, 1996; 149: 831-843
23. Tanizawa S, Ueda M, van der Loos CM, van der Wal AC, Becker AE: Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study. Heart, 1996; 6: 549-556
24. Ohishi M, Ueda M, Rakugi H, Okamura A, Naruko T, Becker AE, Hiwada K, Kamitani A, Kamide K, Higaki J, Ogihara T: Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation, 1997; 96: 3328-3337
25. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, Malden LT, Masuko H, Sato H: Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science, 1990; 248: 1009-1012
26. van der Loos CM, Becker AE, van den Oord JJ: Practical suggestions for successful immunoenzyme double-staining experiments. Histochem J, 1993; 25: 1-13
27. Bazzoni G, Dejana E, Del Maschio A: Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica, 1991; 76: 491-499
28. Aukrust P, Waehre T, Damås JK, Gullestad L, Solum NO: Inflammatory role of platelets in acute coronary syndromes. Heart, 2001; 86: 605-606
29. Kayo S, Ikura Y, Suekane T, Shirai N, Sugama Y, Ohsawa M, Adachi K, Watanabe K, Nakamura S, Fujiwara Y, Oshitani N, Higuchi K, Maeda K, Hirakawa K, Arakawa T, Ueda M: Close association between activated platelets and neutrophils in the active phase of ulcerative colitis in humans. Inflamm Bowel Dis, 2006; 8: 727-735
30. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Müller KM: Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol, 2000; 35: 157-163
31. Kumar A, Hoover JL, Simmons CA, Lindner V, Shebuski RJ: Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation, 1997; 96: 4333-4342
32. Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S: Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris. Am J Cardiol, 2000; 86: 1057-1062
33. Welt FG, Edelman ER, Simon DI, Rogers C: Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol, 2000; 20: 2553-2558
34. Graff J, Klinkhardt U, Schini-Kerth VB, Harder S, Franz N, Bassus S, Kirchmaier CM: Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor. J Pharmacol Exp Ther, 2002; 300: 952-957
35. Wanibuchi H, Ueda M, Dingemans KP, Becker AE: The response to percutaneous transluminal coronary angioplasty: an ultrastructural study of smooth muscle cells and endothelial cells. Cardiovasc Pathol, 1992; 1: 295-306
36. Reidy MA, Chopek M, Chao S, McDonald T, Schwartz SM: Injury induces increase of von Willebrand factor in rat endothelial cells. Am J Pathol, 1989; 134: 857-864
37. Bosmans JM, Kockx MM, Vrints CJ, Bult H, De Meyer GR, Herman AG: Fibrin(ogen) and von Willebrand factor deposition are associated with intimal thickening after balloon angioplasty of the rabbit carotid artery. Arterioscler Thromb Vasc Biol, 1997; 17: 634-645